Categories: The Charlton Centre

COVID-19 Vaccination Phase 2 Includes Compromised Patients

In writing this blog, we are all aware that the vaccine distribution continues to be updated.  Phase 2 of vaccine distribution is to include patients who have compromising conditions or treatments that suppress the immune system,  regardless of the person’s age.  The intention is for this to begin in April and in some health units, this has already happened.  This may be an opportunity for you to be vaccinated before your age group is eligible.  The question is, what information will be required when booking in order to receive a vaccine under this ‘at risk’ category.  Many patients have been asking for a note from their specialist at their most recent visit confirming to confirm their condition and that they are a person of increased risk.  I recently heard from an individual whom public health had reached out to directly,  based on a list public health received from a local family physician listing their “at-risk” patients.   Each public health unit may be implementing Phase 2 differently. What we do know is that when being vaccinated you will be asked if you are immunocompromised and you must be able to confirm that you have had a conversation with a health professional in your care about any alterations in your medications that may be needed when receiving the COVID-19 vaccine. Ensure you are prepared to answer such questions to avoid being turned away for vaccine administration.

Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Saphnelo for Lupus

Saphnelo (anifrolumab) is a one-of-a-kind therapy by AstraZeneca for the treatment of moderate to severe…

2 weeks ago

A New Treatment Option for Alopecia Areata

On December 4, 2023, Health Canada approved Pfizer’s Litfulo (ritlecitinib). Litfulo is a once-daily oral…

4 weeks ago

Infliximab Now Available As An Injection for Crohn’s and Ulcerative Colitis Patients

Infliximab is a protein-based medication referred to as a biologic that treats many immune-mediated conditions. …

2 months ago

A New Treatment For Ulcerative Colitis

On October 3rd, 2023, Health Canada approved Eli Lilly’s newest biologic for the treatment of…

2 months ago

Show Love to your Heart

As February is heart month, today is an excellent occasion to really show why we love our hearts and…

3 months ago

Charlton Infusion Clinic Expansion

To better serve our Hamilton and area patients, we have expanded and moved our Stoney…

3 months ago